ACE2 and depressive disorder: To investigate the impact of ACE2 gene variants on the antidepressant efficacy of SSRIs, a randomized, controlled trial was completed, involving 200 patients with newly diagnosed depression who underwent fluoxetine or sertraline for 6 weeks, along with ACE2 allele genotyping (71).